Taizhou Fudan-Zhangjiang Pharmaceutical Co., Ltd.
|Taizhou Fudan-Zhangjiang Pharmaceutical Co., Ltd. Patent applications|
|Patent application number||Title||Published|
|20110117082||Soluble Tumor Necrosis Factor Receptor Mutant - A soluble tumor necrosis factor receptor 2 (TNFRII) mutant has an amino acid substitution at position 92Glu compared with the wild TNFRII. The mutant improves the cytotoxicity capacity of neutralizing TNFalpha and lymphotoxin. The mutant and fusion protein comprising it are useful for the treatment of TNFalpha and lymphotoxin related diseases.||05-19-2011|